OPTIMUM LT · AC058B303
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A multicenter, noncomparative extension study of AC-058B301 evaluating the long-term safety, tolerability and disease control of ponesimod 20 mg in participants with relapsing multiple sclerosis.
Sponsor: JANSSEN ACTELION
Phase: III
Area: Neuroimmunology